U.S. Stem Cell

17 articles about U.S. Stem Cell

• Mark Borman Appointed Chairman of the Board of USRM

  3/9/2022

  U.S. Stem Cell, Inc., a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions has appointed Mark Borman as Chairman of the Board as Dr. William P. Murphy Jr transitions to Chairman Emeritus.

• Northstar Biotech and USRM BOD Members Reinvest in the Company

  2/23/2021

  U.S. Stem Cell, Inc. (OTC PINK:USRM), a leader in the development of proprietary, physician-based, and novel regenerative medicine solutions, is pleased to announce the efforts of NorthStar Biotech Group and USRM Board Members to reinvest in U.S. Stem Cell, Inc.

• USRM Oral Argument in Appeal from FDA Enforcement Action

  1/19/2021

  SUNRISE, FL / ACCESSWIRE / January 19, 2021 / U.S. Stem Cell, Inc. (OTC PINK:USRM), a leader in the development of proprietary, physician-based, and novel regenerative medicine solutions, is pleased to announce that oral arguments in the case United States v. U.S. Stem Cell Clinic, LLC, et al., took place on January 13, 2021, before the federal Eleventh Circuit Court of Appeals.

• Corrected: USRM Posts Earnings for Second Quarter 2019

  8/9/2019

  U.S. Stem Cell, Inc., a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, announced earnings for the second quarter that ended June 30, 2019.

• USRM Posts Earnings for Second Quarter 2019

  8/7/2019

  U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced earnings for the second quarter that ended June 30, 2019.

• USRM Posts Financial Results for First Quarter 2019

  5/7/2019

  U.S. Stem Cell, Inc. announced financial results for the first quarter ended March 31, 2019.

• Dr. Comella to Present at Paleo f(x) Conference in Austin, Texas

  4/26/2019

  U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, is pleased to announce its Chief Science Officer, Dr. Kristin Comella, will present at the 2018 Paleo f(x) Conference Sunday, April 28, at the Palmer Events Center in Austin, Texas.

• USRM Posts Increase in Revenue and Profit Margin for 2018

  3/13/2019

  U.S. Stem Cell is a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions

• USRM announces U.S. Stem Cell Clinic Expansion of Products and Services

  12/6/2018

  Increasing Market Demand for Regenerative Therapies Drives Diversification

• USRM Posts 25% Nine Month Revenue Increase From 3Q 2017

  11/7/2018

  U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced third quarter results for this year and comparatively from last year, for the nine months ended Sept. 30, 2018.

• Adipose Stem Cells Demonstrate Effectiveness in Repairing Decubitus Ulcers

  10/9/2018

  Paper Published by USRM Chief Science Officer in Journal of Medical Cases

• USRM Posts Profitable Results for Second Quarter 2018

  8/8/2018

  Continues to Post Increases in Revenue for Second Straight Year

• 'Renewing Our Heroes' to Provide USRM Stem Cell Protocol to First Responders

  6/5/2018

  U.S. Stem Cell, Inc. announced Renewing Our Heroes will now offer USRM stem cell procedures and protocols to its recipients following injuries and conditions that occur in the line of duty.

• USRM Chief Science Officer to Present at Fifth Annual Cell Surgical World Conference

  6/1/2018

  U.S. Stem Cell, Inc. announced its Chief Science Officer, Dr. Kristin Comella, will be presenting at the Fifth Annual Cell Surgical World Conference.

• USRM Chief Science Officer Featured in Live Interview for Biohacker Summit in Helsinki

  5/3/2018

  U.S. Stem Cell, Inc. announced its Chief Science Officer, Dr. Kristin Comella, appeared live today as a featured guest for the Biohacker Summit blog

• Newest Clinic Opens Today at The Villages in Central Florida

  4/9/2018

  U.S. Stem Cell, Inc. announced the opening its first USRM clinic in North Central Florida.

• USRM Reaches Key Sales Milestone of Proprietary Adipocell Product

  1/15/2018

  Adipocell, which has been developed, marketed and distributed by USRM, enables physicians to separate potent stem cells from a patient's own fat cells.